Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors

Photochemical and Photobiological Sciences

Volumn 3, Issue 8, 2004, Pages 812-816

  Korbelik, Mladen ^a   Sun, Jinghai ^a   Cecic, Ivana ^a   Serrano, Katherine ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PHOTOFRIN; S 8026; STREPTOKINASE; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; UROKINASE; Z 42500; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; TUMOR MODEL;

EID: 4644286775     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b315663J     Document Type: Article

References (22)

1. T. J. Dougherty C. J. Gomer B. W. Henderson G. Jori D. Kessel M. Korbelik J. Moan Q. Peng Photodynamic Therapy J. Natl. Cancer Inst. 1998 90 889-905.
2. I. Cecic, B. Stott, J. Sun and M. Korbelik, Relevance of innate immunity recognition of altered self in the induction of host response associated with photodynamic therapy, in Recent Research Development in Cancer, ed. S. G. Pandalai, Transworld Research Network, Trivandrum, India, vol. 5, in press.
3. M. Korbelik and I. Cecic Mechanism of tumor destruction by photodynamic therapy, in Handbook of Photochemistry and Photobiology, ed. H. S. Nalwa, American Scientific Publishers, Stevenson Ranch, CA, vol. 4, 2003, pp. 39–77.
4. N. R. Cooper, Biology of the complement system, in Inflammation: Basic Principles and Clinical Correlations, ed. J. I. Galin and R. Snyderman, Lippincott Williams & Wilkins, Philadelphia, PA, 1999, pp. 281–315.
5. K. Elward P. Gasque “Eat me” and “don’t eat me” signals govern the innate immune response and tissue repair in the CNS; emphasis on the critical role of the complement system Mol. Immunol. 2003 40 85-94.
6. I. Cecic M. Korbelik Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors Cancer Lett. 2002 183 43-51.
7. L. Clemenza F. Dieli M. Cicardi A. Salerno Research on complement: old issues revisited and a novel sphere of influence Trends Immunol. 2003 24 292-295.
8. Y. Y. Maeda G. Chihara The effects of neonatal thymectomy on the antitumor activity of lentinan, carboxymethylpachymaran and zymosan, and their effects on various immune rsponses Int. J. Cancer 1973 11 153-161.
9. P. D. Cooper Solid phase activators of the alternative pathway of complement and their use in vivo, in Activators and Inhibitors of Complement, ed. R. B. Sim, Kluwer Academic Publishers, Amsterdam, 1993, pp. 69–106.
10. W. T. Bradner D. A. Clarke C. C. Stock Stimulation of host defense against experimental cancer. I. Zymosan and sarcoma 180 in mice Cancer Res. 1958 18 347-351.
11. T. J. H. Volman R. J. A. Goris M. van der Jagt F. A. J. van de Loo T. Hendriks Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase Crit. Care Med. 2002 30 1553-1559.
12. S. Oren I. Maslovsky M. Schlesinger L. Resin Complement activation in patients with acute myocardial infarction treated with streptokinase Am. J. Med. Sci. 1998 315 24-29.
13. G. A. Ewald P. R. Eisenberg Plasmin-mediated activation of contact system in response to pharmacological thrombolysis Circulation 1995 91 28-36.
14. M. Korbelik G. Krosl Photofrin accumulation in malignant and host cell populations of various tumours Br. J. Cancer 1996 73 506-513.
15. J. Sun I. Cecic C. S. Parkins M. Korbelik Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumors Photochem. Photobiol. Sci. 2002 1 690-695.
16. Y. S. Taktak B. Stenning Solid pahse enzyme immunoassay for the quantification of serum amyloid P (SAP) and complement component 3 (C3) proteins in acute-phase mouse sera Horm. Metab. Res. 1992 24 371-374.
17. M. I. Gyongyossy S. N. Assimeth Isolation of the third component of mouse complement J. Immunol. 1977 118 1032-1035.
18. H.-P. T. Ekre B. Fjellner Ö. Hägermark Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions Int. J. Immunopharmacol. 1986 8 277-286.
19. L. D. Shultz P. A. Schwietzer S. W. Christianson B. Gott I. B. Schweitzer B. Tennant S. McKenna L. Mobraaten T. V. Rajan D. L. Greiner E. H. Leiter Multiple defects in innate and adaptive immunological function in NOD/Ltz-scid mice J. Immunol. 1995 154 180-191.
20. W. T. Schaiff P. R. Eisenberg Direct induction of complement activation by pharmacologic activation of plasminogen Coron. Artery Dis. 1997 8 9-18.
21. I. Cecic C. S. Parkins M. Korbelik Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors Photochem. Photobiol. 2001 74 712-720.
22. I. Cecic and M. Korbelik, unpublished.